AVB vs DMAC · P/E 23, rev $2.91B vs $157.4M cap
AvalonBay Communities Inc (AVB) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
AvalonBay Communities Inc (AVB) is a reit - residential company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported AVB revenue for 2024-12-31 was $2.91B. Net income was $1.08B. Revenue was up 5.3% from 2023-12-31 to 2024-12-31. AVB currently screens at market cap $26.84B and trailing P/E 23.4.
DMAC does not have a complete income-statement cache yet.
AVB currently screens at market cap $26.84B and trailing P/E 23.4. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the AVB and DMAC stock pages for the full models.
Not investment advice.